Stock Track | Structure Therapeutics Plummets 8.94% as Trump's HHS Pick Could Threaten Weight-Loss Drug Prospects

Stock Track00:24

Structure Therapeutics Inc. (GPCR) saw its stock plummet by 8.94% in intraday trading on Friday, November 15, 2024. The sharp decline in the biopharmaceutical company's shares is likely attributed to concerns surrounding President-elect Donald Trump's potential pick for the Department of Health and Human Services (HHS).

According to reports, Trump has nominated Robert F. Kennedy Jr., a prominent critic of the pharmaceutical industry and weight-loss drugs, to lead the HHS. Kennedy has argued that the government should promote healthy eating habits instead of relying on expensive weight-loss medications, such as the GLP-1 class of drugs.

Structure Therapeutics is currently developing an oral GLP-1 drug called GSBR-1290 for weight loss and metabolic disorders. If appointed, Kennedy's stance against weight-loss drugs could pose a significant challenge to the company's prospects in this area, prompting investors to re-evaluate their positions in the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160977115?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-16 00:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160977115","market":"hk","top_or_hot":-1,"title":"Stock Track | Structure Therapeutics Plummets 8.94% as Trump's HHS Pick Could Threaten Weight-Loss Drug Prospects","media":"Stock Track","content":"<p>Structure Therapeutics Inc. (GPCR) saw its stock plummet by 8.94% in intraday trading on Friday, November 15, 2024. The sharp decline in the biopharmaceutical company's shares is likely attributed to concerns surrounding President-elect Donald Trump's potential pick for the Department of Health and Human Services (HHS).</p>\n\n<p>According to reports, Trump has nominated Robert F. Kennedy Jr., a prominent critic of the pharmaceutical industry and weight-loss drugs, to lead the HHS. Kennedy has argued that the government should promote healthy eating habits instead of relying on expensive weight-loss medications, such as the GLP-1 class of drugs.</p>\n\n<p>Structure Therapeutics is currently developing an oral GLP-1 drug called GSBR-1290 for weight loss and metabolic disorders. If appointed, Kennedy's stance against weight-loss drugs could pose a significant challenge to the company's prospects in this area, prompting investors to re-evaluate their positions in the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Structure Therapeutics Plummets 8.94% as Trump's HHS Pick Could Threaten Weight-Loss Drug Prospects</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Structure Therapeutics Plummets 8.94% as Trump's HHS Pick Could Threaten Weight-Loss Drug Prospects\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-16 00:24 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Structure Therapeutics Inc. (GPCR) saw its stock plummet by 8.94% in intraday trading on Friday, November 15, 2024. The sharp decline in the biopharmaceutical company's shares is likely attributed to ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GPCR","symbol_name":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","start_time":0,"source_url":"","article_id":"1160977115","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160977115","pubTimestamp":1731687861,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Structure Therapeutics Inc.  saw its stock plummet by 8.94% in intraday trading on Friday, November 15, 2024. The sharp decline in the biopharmaceutical company's shares is likely attributed to concerns surrounding President-elect Donald Trump's potential pick for the Department of Health and Human Services .According to reports, Trump has nominated Robert F. Kennedy Jr., a prominent critic of the pharmaceutical industry and weight-loss drugs, to lead the HHS. Kennedy has argued that the governm","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GPCR":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD"},"translate_title":"由于特朗普的HHS选择可能威胁减肥药前景，Structure Therapeutics股价暴跌8.94%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GPCR":1},"content_text":"Structure Therapeutics Inc. (GPCR) saw its stock plummet by 8.94% in intraday trading on Friday, November 15, 2024. The sharp decline in the biopharmaceutical company's shares is likely attributed to concerns surrounding President-elect Donald Trump's potential pick for the Department of Health and Human Services (HHS).\nAccording to reports, Trump has nominated Robert F. Kennedy Jr., a prominent critic of the pharmaceutical industry and weight-loss drugs, to lead the HHS. Kennedy has argued that the government should promote healthy eating habits instead of relying on expensive weight-loss medications, such as the GLP-1 class of drugs.\nStructure Therapeutics is currently developing an oral GLP-1 drug called GSBR-1290 for weight loss and metabolic disorders. If appointed, Kennedy's stance against weight-loss drugs could pose a significant challenge to the company's prospects in this area, prompting investors to re-evaluate their positions in the stock.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160977115"}